BX Swiss TOP 30 CHF
1.283,58
PKT
+0,59
PKT
+0,05
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.05.22 | Zurich Insurance Overweight | Barclays Capital | |
10.05.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
09.05.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
06.05.22 | Swiss Re Hold | Deutsche Bank AG | |
06.05.22 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.05.22 | Roche Buy | Jefferies & Company Inc. | |
05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.05.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
05.05.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
04.05.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
02.05.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
02.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
29.04.22 | UBS Sector Perform | RBC Capital Markets | |
28.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
28.04.22 | UBS Hold | Deutsche Bank AG | |
28.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
28.04.22 | UBS Underweight | Barclays Capital | |
28.04.22 | UBS Neutral | UBS AG | |
28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
28.04.22 | Holcim Hold | Deutsche Bank AG | |
28.04.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
27.04.22 | Richemont Buy | HSBC | |
27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.22 | UBS Buy | Goldman Sachs Group Inc. | |
27.04.22 | UBS Outperform | Credit Suisse Group | |
27.04.22 | Novartis Neutral | Credit Suisse Group | |
27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.22 | UBS Buy | Deutsche Bank AG | |
27.04.22 | UBS Neutral | Goldman Sachs Group Inc. | |
27.04.22 | Novartis Neutral | UBS AG | |
27.04.22 | Novartis Sell | Deutsche Bank AG | |
27.04.22 | UBS Sector Perform | RBC Capital Markets | |
27.04.22 | UBS Outperform | RBC Capital Markets | |
27.04.22 | UBS Hold | Jefferies & Company Inc. | |
27.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
27.04.22 | UBS Underweight | Barclays Capital | |
27.04.22 | UBS Equal Weight | Barclays Capital | |
26.04.22 | Novartis Neutral | UBS AG | |
26.04.22 | Roche Neutral | Credit Suisse Group | |
26.04.22 | Roche Buy | Deutsche Bank AG |